People are our greatest asset.
We have put together an incredibly talented team and continue to support them through their career development. Pictor aims to provide a safe, healthy, innovative and engaging workplace for all of our employees across NZ, U.S. and India. Our team is diverse with permanent staff, long term contractors and consultants all blended into a high performing, adaptable and highly capable team.
We have extraordinary depth of experience and knowledge in our key product areas, and highly motivated teams who continue to evolve new products and technologies.
Our extremely capable staff have nine PhD’s, 15 Masters, 12 Bachelor of Science degrees, with a combined total of 444.75 years in scientific research and product development. Overall, they’ve published 89 papers in peer-reviewed scientific journals.
In short, we have some serious scientific horsepower behind our research and product development.
This highly dynamic team is the result of an empowering work culture that promotes continuous development programs to facilitate career progression and personal growth. We further enable our staff with a strong policy of promoting from within.
Chief Operations Officer
Graduating from Massey University with a Bachelor of Food Technology, Howard’s early career emerged as a driving force in the New Zealand dairy industry with NZ Co-op Dairy Co, Alfa Laval, NZ Dairy Board and Kiwi Dairies. He enabled commitments to invest $150 million in an ag-biotechnology start-up company, ViaLactia, and with the late Professor Ross Clark co-founded Tercica; an Auckland start-up which relocated to the USA, in-licensed and then had IGF-1 approved as a drug. Ultimately, Tercica was listed on the NASDAQ exchange.
Howard then returned to New Zealand and became Executive Director for Direct Capital’s $100 million life sciences fund, BioPacificVentures. He then spent six years working in the dairy industry in China, prior to joining Pictor as CEO.
His career has been hallmarked by fundraising, commercialising technology, developing early-stage companies, and sales and marketing.
Chief Medical Officer
Dr. Tadd Lazarus
Dr. Lazarus, who is based in San Diego, California and Austin, Texas, brings extensive experience as Medical Director and Chief Medical officer in the biotechnology and in vitro diagnostic (IVD) industries. He has special interests and expertise in medical diagnostics, molecular biology, medical marketing, companion diagnostics, reimbursement, and regulatory affairs.
Dr. Lazarus has spent more than 12 years as North American Medical Director for Roche Diagnostics (US), focused on routinising molecular diagnostics in the care of patients with infectious diseases, with a focus on HIV/AIDS and Viral Hepatitis. As Chief Medical Officer at Gen-Probe, now Hologic, Dr. Lazarus designed a portfolio of viral infectious diseases assays that are both highly differentiated and globally accepted.
As Chief Medical Officer of QIAGEN, he made significant progress on Capitol Hill with regards to appropriate reimbursement for FDA-approved oncology companion diagnostics.
Chief Financial Officer
Steven joined Pictor in 2022 and is responsible for managing all finance and accounting operations. developing financial strategy, including risk minimisation plans and opportunity forecasting.
Prior to joining Pictor Steven has over 20 years of senior financial experience in large asset owning and international distribution companies based in both New Zealand and overseas.
Steven is a Chartered Accountant and holds an MBA from London Business School.
VP India, Director of Sales & Marketing – Europe/Asia
Sanjay is an astute sales, marketing, and business development professional with 22 years of experience in healthcare, medical equipment, clinical diagnostics and medical devices.
His global business expertise spans the Indian sub-continent, Asia, Middle East, Europe and South America.
A passionate and dedicated business professional, Sanjay has worked with various large American, European and Indian multinational organisations such as Siemens, Godrej Industries, Depuy Synthes (Johnson & Johnson), ConvaTec, Meril Life Sciences in India and Internationally through wholly owned subsidiaries.
Director of Sales & Marketing – North America & Oceania
Matt has almost 20 years’ experience within the MedTech sector having worked in sales and marketing roles for Merck, Medtronic and Cardinal Health.
He also headed the Zuru Health PPE business during the COVID-19 pandemic before joining Pictor. With university qualifications in both business and science, Matt believes in a data-driven approach when setting sales and marketing strategies.
Matt takes a customer/patient centric approach to market development activities and product/clinical support.
Director of Commercial Operations
A former Executive at Merck with 18 years’ experience overseas, Andrew has global experience in working on early new products, developing preclinical and clinical programs with R&D, assessing commercial opportunities and partnerships, and leading Sales and Marketing teams to successfully commercialise products in markets across Asia Pacific, Europe, and the US.
With prior commercial responsibility for over 11 countries, Andrew is highly skilled at identifying and facilitating market launches aligning with strategic decisions and policy frameworks.
Director of Research & Product Development
Dr. Natasha Gordon
Dr. Gordon has always had an interest in infectious diseases and immunity, completing her PhD in molecular medicine at the University of Auckland, followed by an Enterprise Ireland commercial research fellowship at Maynooth University (Kildare, Ireland).
She later joined Armid Healthgroup (Dublin, Ireland) and set up their research and development department as lead scientist. Dr. Gordon has been an industry member of the National Standards Authority of Ireland committee for ISO standard development and an industry research liaison to many academic institutes.
A key focus of her research at Pictor has been the development of highly innovative diagnostic tools that enable the understanding of an individual’s immune system helping to formulate specialised treatment plans, the CE marked PictArray™ SARS-CoV-2 IgG ELISA is an exciting outcome of this research.
Manufacturing Operations Manager
Dr. Andrea Kinga-Furuya
Andrea earned her PhD in Microbiology and Immunology from Albany Medical College. She then joined the Diagnostic Immunology Laboratory as a research scientist at the Wadsworth Centre of the New York State Department of Health. During her time at the Wadsworth Centre, she acquired New York State’s Certificate of Qualification as a laboratory director in Diagnostic Immunology.
In addition, she was also appointed Clinical Assistant Professor at the State University of Albany and served as an Adjunct Faculty at Albany College of Pharmacy, Albany, New York. At Pictor, Andrea oversees the manufacturing process of the current diagnostic products and logistics operations.
She also oversees the Pictor product transfer to our manufacturing partners at South Pacific Sera (SPS) in Timaru.
Bibin Bose Kottuvilayil
Bibin is a qualified pharmacist with extensive knowledge of the quality management system.
He has completed a Master of Pharmacy and has 13 years of experience developing and implementing effective methods and processes in a manufacturing environment.
Bibin keeps himself and Pictor current on relevant quality standards including biotech, pharmaceuticals, medical devices, and the Cosmetics Quality & Regulatory standards of the FDA, Europe, China, India, and various ISO standards.